Epac/cAMP-GEF, A Novel Intracellular cAMP Receptor

Epac/cAMP-GEF,一种新型细胞内 cAMP 受体

基本信息

  • 批准号:
    6743684
  • 负责人:
  • 金额:
    $ 27.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exchange protein directly activated by cAMP (Epac) or cAMP-activated guanine nucleotide exchange factor (cAMP-GEF) is a novel intracellular cAMP receptor, which directly activates Rap1, a Ras-like small G protein. The discovery of Epac opens up a new dimension in the study of cAMP-mediated signaling. In particular, the finding of a second intracellular cAMP receptor in addition to PKA suggests that some, or even the majority of cAMP actions described in the vast cAMP literature, do not act through the activation of PKA alone, as previously believed. Recent studies also suggest that Epac is a multifunctional protein that is capable of mediating cAMP actions differentially from PKA. The major goal of this proposal is to dissect the cAMP-signaling pathways, with particular emphasis on the structure and function of the novel cAMP sensor protein Epac. Specifically we will: 1) study subcellular targeting of Epac, particularly the mitochondrial localization, and its regulation that is important for Epac's cellular functions using immunofluorescence microscopy and GFP (green fluorescent protein) fusion protein; 2) test the hypothesis that tubulin/microtubule, acting either as an upstream regulator or downstream effector, is a bona fide Epac cellular partner by examining the biochemical and functional consequences of Epac and tubulin/microtubule interaction; 3) map the conformational changes associated with the activation of Epac by cAMP and Epac- Rap1 and Epac-tubulin interactions that are important to Epac functions using chemical protein footprinting and a sensitive MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mapping technique. Our long-term goal is to understand how the disparate functions of cAMP binding and guanine nucleotide exchange activity are assembled and coordinated to mediate cAMP signaling at the molecular and structural levels by dissecting Epac-mediated cellular and biochemical interactions. These proposed studies are essential for further understanding cAMP signaling pathways and elucidating the actions of cAMP in cellular regulation under normal and pathologic states.
描述(由申请人提供): cAMP直接激活的交换蛋白(Epac)或cAMP激活的鸟嘌呤核苷酸交换因子(cAMP-GEF)是一种新型的细胞内cAMP受体,它直接激活Ras样小G蛋白Rap 1。Epac的发现为cAMP介导的信号转导研究开辟了新的方向。特别地,除了PKA之外的第二种细胞内cAMP受体的发现表明,大量cAMP文献中描述的一些或甚至大多数cAMP作用并不像以前认为的那样通过单独激活PKA起作用。最近的研究还表明,Epac是一种多功能蛋白,能够介导cAMP的行动不同于PKA。该提案的主要目标是剖析cAMP信号通路,特别强调新型cAMP传感器蛋白Epac的结构和功能。具体而言,我们将:1)使用免疫荧光显微镜和GFP研究Epac的亚细胞靶向,特别是线粒体定位,及其对Epac的细胞功能的重要调节(绿色荧光蛋白)融合蛋白; 2)检验微管蛋白/微管,作为上游调节物或下游效应物,是一个真正的Epac细胞伴侣,通过检查Epac和微管蛋白/微管相互作用的生化和功能后果; 3)使用化学蛋白质足迹法和灵敏的MALDI-TOF技术,绘制与通过cAMP和Epac-Rap 1和Epac-微管蛋白相互作用激活Epac相关的构象变化,所述相互作用对Epac功能是重要的(基质辅助激光解吸/电离飞行时间)映射技术。 我们的长期目标是通过剖析Epac介导的细胞和生化相互作用,了解cAMP结合和鸟嘌呤核苷酸交换活性的不同功能是如何组装和协调的,以在分子和结构水平上介导cAMP信号传导。这些研究对于进一步了解cAMP信号通路和阐明cAMP在正常和病理状态下的细胞调节作用是必不可少的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XIAODONG CHENG其他文献

XIAODONG CHENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XIAODONG CHENG', 18)}}的其他基金

Significance of Epac signaling in renal Na+ handling and hypertension
Epac 信号在肾钠处理和高血压中的意义
  • 批准号:
    10864073
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Epac1 as a novel therapeutic target for diabetic retinopathy
Epac1作为糖尿病视网膜病变的新型治疗靶点
  • 批准号:
    10689112
  • 财政年份:
    2022
  • 资助金额:
    $ 27.12万
  • 项目类别:
Exchange Protein directly Activated by cAMP (EPAC): Structure, Function and Therapeutics
cAMP 直接激活的交换蛋白 (EPAC):结构、功能和治疗
  • 批准号:
    10198941
  • 财政年份:
    2017
  • 资助金额:
    $ 27.12万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    9250048
  • 财政年份:
    2014
  • 资助金额:
    $ 27.12万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    9038248
  • 财政年份:
    2014
  • 资助金额:
    $ 27.12万
  • 项目类别:
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
针对 EPAC1 的立克次体病新型疗法的临床前开发
  • 批准号:
    8694342
  • 财政年份:
    2014
  • 资助金额:
    $ 27.12万
  • 项目类别:
Novel Pharmacological Probes Targeting Exchange Proteins Activated by cAMP (EPAC)
针对 cAMP 激活的交换蛋白的新型药理学探针 (EPAC)
  • 批准号:
    8482964
  • 财政年份:
    2013
  • 资助金额:
    $ 27.12万
  • 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
  • 批准号:
    8477859
  • 财政年份:
    2010
  • 资助金额:
    $ 27.12万
  • 项目类别:
High throughput assay for novel pharmacological probes targeting cAMP signaling
针对 cAMP 信号传导的新型药理学探针的高通量测定
  • 批准号:
    7991500
  • 财政年份:
    2010
  • 资助金额:
    $ 27.12万
  • 项目类别:
Genetic Screening:Oncogene RAS-Based Inhibi*(RMI)
基因筛查:Oncogene RAS-Based Inhibi*(RMI)
  • 批准号:
    7058055
  • 财政年份:
    2005
  • 资助金额:
    $ 27.12万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.12万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 27.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了